Adenocarcinoma, Mucinous

• 

  Subject Areas on Research

  • "Reverse-figure 3" sign in duodenal adenocarcinoma arising in a villous adenoma: radiographic demonstration. 
  • A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas. 
  • A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia. 
  • Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. 
  • Advanced stage primary mucinous ovarian carcinoma. Where do we stand ? 
  • Analgesic medication use and risk of epithelial ovarian cancer in African American women. 
  • Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. 
  • Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. 
  • Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm. 
  • Common variants at 19p13 are associated with susceptibility to ovarian cancer. 
  • Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. 
  • Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms. 
  • Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. 
  • Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. 
  • Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity. 
  • Endocrine Mucin-Producing Sweat Gland Carcinoma of the Eyelid Associated With Mucinous Adenocarcinoma. 
  • Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. 
  • GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. 
  • Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. 
  • Genome-wide significant risk associations for mucinous ovarian carcinoma. 
  • High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. 
  • Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT. 
  • In vivo and in vitro propagation of intraductal papillary mucinous neoplasms. 
  • Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. 
  • Insular carcinoid of ovary associated with malignant mucinous tumors. 
  • Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. 
  • Intraductal papillary mucinous neoplasm. 
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. 
  • Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? 
  • Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. 
  • Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. 
  • Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion? 
  • Low-grade Appendiceal Mucinous Neoplasm and Endometriosis: Incidental Coincident Pathologies at Cesarean Section. 
  • Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians. 
  • Molecular markers of therapeutic resistance in breast cancer. 
  • Mucinous (colloid) adenocarcinoma of the lung. 
  • Mucinous adenocarcinoma arising in rectovaginal fistulas associated with Crohn's disease. 
  • Mucinous adenocarcinoma of the prostate. 
  • Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature. 
  • Novel prognostic markers for patients with triple-negative breast cancer. 
  • Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. 
  • Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells. 
  • Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia. 
  • Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. 
  • Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm. 
  • Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. 
  • Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma. 
  • Peak density of immature nerve cells occurs with high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas. 
  • Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. 
  • Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. 
  • Primary mucinous carcinoma of the eyelid: a clinicopathologic and immunohistochemical study of 4 cases and an update on recurrence rates. 
  • Prostatic mucinous adenocarcinoma. A Cowper gland carcinoma mimicker. 
  • Recurrence patterns of intraductal papillary mucinous neoplasms of the pancreas on enhanced computed tomography. 
  • Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. 
  • Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. 
  • Risk factors for ovarian cancers with and without microsatellite instability. 
  • Risk factors for ovarian cancers with and without microsatellite instability. 
  • SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. 
  • Should all branch-duct intraductal papillary mucinous neoplasms be resected? 
  • Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. 
  • The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN. 
  • The Oncogenesis in Patients With Pancreatic Intraductal Papillary Mucinous Neoplasms: Taking the Thread From the Beginning. 
  • The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer. 
  • The management of intraductal papillary mucinous neoplasms of the pancreas. 
  • The natural history of colorectal carcinoma in adolescents. 
  • The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction. 
  • The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. 
  • Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. 
  • Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. 
  • Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas. 
  • Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. 
  • rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute